• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

CD43 (Bra7G), 0.2mg/mL

Catalog number BNUB0302-500

Price for BNUB0302-500

Sign In for Pricing

Size / count 1x 500 µL

About this product

This antibody recognizes a cell surface glycoprotein of 95/115/135 kDa (depending upon the extent of glycosylation), identified as CD43 (Workshop V) . Epitope of MAb Bra7G is clearly different from that of MAb DF-T1, called b as opposed to a for DF-T1. 70-90% of T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be a malignant lymphoma, especially a low-grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma. This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL.

Specifications

Catalog number
BNUB0302-500
Size / count
1x 500 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
Galactoglycoprotein, GALGP, GPL115, Leukocyte sialoglycoprotein, Leukosialin, LSN, Sialophorin, SPN
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
SPN
Gene ID
6693
NCBI Gene ID
632188
UniProt
P16150
Swiss Prot
P16150
Host
Mouse
Species Reactivity
Human
Reactivity
CD43
Immunogen
Immature pluripotent human leukemia K562 cells
Target Antigen
CD43
Clonality
Monoclonal
Clone
Bra7G
Type
Primary
Source
Animal
Origin
Animal
Applications
Flow, surface (published) |IF (verified) |IHC, FFPE (verified) |IP (published)
Field of Research
Immunology
Positive Control
Paracortex in a tonsil or a reactive lymph node
Stability
2 years
Concentration
0.2 mg/mL
Buffer
PBS, 0.05% BSA, 0.05% azide
Molecular Weight
95, 115, or 135 kDa
References & Citations
Note: References for this clone sold by other suppliers may be listed for expected applications. Cancer Letters (1994) 81: 81-87. (flow, surface) J Leukoc Biol (1998) 64: 800-802. (immunoprecipitation)
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgM, kappa
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate
Purified, with BSA

Frequently Asked Questions

What is the catalog number for CD43 (Bra7G), 0.2mg/mL?

The catalog number for CD43 (Bra7G), 0.2mg/mL is BNUB0302-500.

What sizes are available for CD43 (Bra7G), 0.2mg/mL?

CD43 (Bra7G), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is CD43 (Bra7G), 0.2mg/mL in stock?

CD43 (Bra7G), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures CD43 (Bra7G), 0.2mg/mL?

CD43 (Bra7G), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for CD43 (Bra7G), 0.2mg/mL?

Estimated delivery time for CD43 (Bra7G), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for CD43 (Bra7G), 0.2mg/mL?

The safety data sheet for CD43 (Bra7G), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is CD43 (Bra7G), 0.2mg/mL used for?

This antibody recognizes a cell surface glycoprotein of 95/115/135 kDa (depending upon the extent of glycosylation), identified as CD43 (Workshop V) . Epitope of MAb Bra7G is clearly different from that of MAb DF-T1, called b as opposed to a for DF-T1. 70-90% of T-cell lymphomas and from 22-37% of B

What is the molecular weight of the target protein?

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

How long will it take to receive this product if it’s custom made?

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

What is the recommended dilution for this antibody?

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

You Might Also Like
CD4 (EDU-2), CF405S conjugate, 0.1mg/mL
CD4 (EDU-2), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040345-100
CD3e (CRIS-7), CF640R conjugate, 0.1mg/mL
CD3e (CRIS-7), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401050-500
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040525-500
CD54 / ICAM-1 (15.2), CF568 conjugate, 0.1mg/mL
CD54 / ICAM-1 (15.2), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC682853-500
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471073-100
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC680977-100
CD3e (B-B12), CF647 conjugate, 0.1mg/mL
CD3e (B-B12), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471052-500
CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940304-100